Dailypharm Live Search Close

Gov't opposes to suspending reimb¡¤ingredient prescribing

By Lee, Jeong-Hwan | translator Hong, Ji Yeon

24.10.17 05:55:38

°¡³ª´Ù¶ó 0
MOHW says, "It may aggravate patient¡¤pharmacy chaos, and it is a matter of agreement between the gov't and the medical community"

In response to the request to restrict reimbursement of Imotun Cap¡¦"The drug has proven usefulness, requires careful consideration"



The government has opposed the proposed measure, which aims to minimize the chaos in prescription¡¤dispensing by suspending insurance reimbursement or blocking prescription code of drugs when substitute drugs are available.

Suspending reimbursement of drugs covered by insurance is a temporary measure implemented in the case of administrative meaures from the Ministry of Food and Drug Safety (MFDS), such as canceling marketing authorization. The government rationale is that suspending reimbursement due to drug shortages would only confuse patients and pharmacies.

At the time of the separation of prescribing and dispensing of drugs, the government also opposed to the measure to all

Lee, Jeong-Hwan(junghwanss@dailypharm.com)
If you want to see the full article, please JOIN US (click)